|
Breaking News
Tazorac (tazarotene) Gel approved by the FDA in June 1997 for the treatment of stable plaque psoriasis of up to 20 % of body surface area.
Metrogel (metronidazole)Gel received FDA approval in November 1998 for the treatment of moderate to severe acne rosacea.
Elidel (pimecrolimus) Cream received FDA approval in December 2001 for the treatment of mild to moderate atopic dermatitis in patients aged 2 years or more.
Botox Cosmetic (botulinum toxin) was approved by the FDA in April 2002 for the temporary improvement of moderate to severe glabellar wrinkles in adult men and women, ages 65 and younger.
Finacea (azelaic acid) Gel 15% received FDA approval in December 2002 for the treatment of mild to moderate acne rosacea.
Protopic (tacrolimus)Ointmentreceived FDA approval in December 2002 for the treatment of atopic dermatitis in patients aged 2 years.
Amevive (alefacept) became the first biological therapy to be approved by the FDA (in January 2003) for the treatment of moderate to severe plaque psoriasis.
|